EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Advanced biomedical imaging for accurate discrimination and prognostication of mediastinal masses

Scherwin Mahmoudi iD, Leon D Gruenewald, Katrin Eichler, Simon S Martin, Christian Booz, Simon Bernatz, Maximilian Lahrsow, Ibrahim Yel, Jennifer Gotta, Teodora Biciusca iD, Hanin Mohammed, Nicole Suarez Ziegengeist und 11 weitere

European Journal of Clinical Investigation · 2023

DOI: 10.1111/eci.14075 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Clinical Investigation, 2023. Verfasst von Scherwin Mahmoudi und 22 weiteren Autor:innen. Beteiligte Einrichtung: Department of Diagnostic and Interventional Radiology, University Hospital Frankfurt, Frankfurt am Main, Germany. Hauptthemen laut MEDLINE: Thymus Neoplasms, Lymphoma, Mediastinal Neoplasms. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

To investigate the potential of radiomic features and dual‐source dual‐energy CT (DECT) parameters in differentiating between benign and malignant mediastinal masses and predicting patient outcomes.

Methods

In this retrospective study, we analysed data from 90 patients (38 females, mean age 51 ± 25 years) with confirmed mediastinal masses who underwent contrast‐enhanced DECT. Attenuation, radiomic features and DECT‐derived imaging parameters were evaluated by two experienced readers. We performed analysis of variance (ANOVA) and Chi‐square statistic tests for data comparison. Receiver operating characteristic curve analysis and Cox regression tests were used to differentiate between mediastinal masses.

Results

Of the 90 mediastinal masses, 49 (54%) were benign, including cases of thymic hyperplasia/thymic rebound ( n = 10), mediastinitis ( n = 16) and thymoma ( n = 23). The remaining 41 (46%) lesions were classified as malignant, consisting of lymphoma ( n = 28), mediastinal tumour ( n = 4) and thymic carcinoma ( n = 9). Significant differences were observed between benign and malignant mediastinal masses in all DECT‐derived parameters ( p ≤ .001) and 38 radiomic features ( p ≤ .044) obtained from contrast‐enhanced DECT. The combination of these methods achieved an area under the curve of .98 (95% CI, .893–1.000; p < .001) to differentiate between benign and malignant masses, with 100% sensitivity and 91% specificity. Throughout a follow‐up of 1800 days, a multiparametric model incorporating radiomic features, DECT parameters and gender showed promising prognostic power in predicting all‐cause mortality (c‐index = .8 [95% CI, .702–.890], p < .001).

Conclusions

A multiparametric approach combining radiomic features and DECT‐derived imaging biomarkers allows for accurate and noninvasive differentiation between benign and malignant masses in the anterior mediastinum.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Thymus NeoplasmsLymphomaMediastinal NeoplasmsFemaleHumansAdultMiddle AgedAgedTomography, X-Ray ComputedRetrospective Studies

Stichwörter der Autor:innen

artificial intelligenceiodinemediastinal neoplasmmediastinummultidetector computed tomographythymoma

Autor:innen und Institutionen

  • Department of Diagnostic and Interventional Radiology, University Hospital Frankfurt, Frankfurt am Main, Germany.
  • Clinic for Diagnostic and Interventional Radiology, University Hospital Heidelberg, Heidelberg, Germany.
  • Department of Cardiology, Angiology and Pulmonology, University Hospital Heidelberg, Heidelberg, Germany.
  • Department of Diagnostic and Interventional Radiology, Tuebingen University Hospital, Tuebingen, Germany.
  • Department of Biomedical Sciences and Morphological and Functional Imaging, University Hospital Messina, Messina, Italy.

ORCID-Profile: Scherwin Mahmoudi, Teodora Biciusca, Tommaso D'Angelo, Vitali Koch

Zitieren

APA

Mahmoudi, S., Gruenewald, L. D., Eichler, K., Martin, S. S., Booz, C., Bernatz, S., Lahrsow, M., Yel, I., Gotta, J., Biciusca, T., Mohammed, H., Ziegengeist, N. S., Torgashov, K., Hammerstingl, R. M., Sommer, C. M., Weber, C., Almansour, H., Bucolo, G., D'Angelo, T., …, & Koch, V. (2023). Advanced biomedical imaging for accurate discrimination and prognostication of mediastinal masses. European Journal of Clinical Investigation. https://doi.org/10.1111/eci.14075

Vancouver

Mahmoudi S, Gruenewald LD, Eichler K, Martin SS, Booz C, Bernatz S, et al. Advanced biomedical imaging for accurate discrimination and prognostication of mediastinal masses. European Journal of Clinical Investigation. 2023. doi:10.1111/eci.14075

BibTeX
@article{Mahmoudi2023,
  author = {Mahmoudi, Scherwin and Gruenewald, Leon D and Eichler, Katrin and Martin, Simon S and Booz, Christian and Bernatz, Simon and Lahrsow, Maximilian and Yel, Ibrahim and Gotta, Jennifer and Biciusca, Teodora and Mohammed, Hanin and Ziegengeist, Nicole Suarez and Torgashov, Katerina and Hammerstingl, Renate M and Sommer, Christof M and Weber, Christophe and Almansour, Haidara and Bucolo, Giuseppe and D'Angelo, Tommaso and Scholtz, Jan-Erik and Gruber-Rouh, Tatjana and Vogl, Thomas J and Koch, Vitali},
  title = {Advanced biomedical imaging for accurate discrimination and prognostication of mediastinal masses},
  journal = {European Journal of Clinical Investigation},
  year = {2023},
  doi = {10.1111/eci.14075}
}
Kostenlos starten →